![Olubukola Ayodele: Extending the deadline for Vanessa Moss Prize abstract submissions](https://oncodaily.com/pub/uploads/2024/08/1690381872013-1-e1723900690202.png)
Olubukola Ayodele: Extending the deadline for Vanessa Moss Prize abstract submissions
Olubukola Ayodele shared on X:
“Are you currently participating in projects aimed at addressing cancer health disparities, either within your local community or on a global scale?
I would like to extend an invitation for you to highlight your endeavors by submitting an abstract for the prestigious Vanessa Moss prize. The top 10 abstracts will receive publication in ecancer, and the most outstanding abstract will be presented orally during the Cancer Health Disparities Day Session on Friday, November 15, 2024, as part of the esteemed London Global Cancer Week.
The deadline for abstract submission is August 25, 2024. Further details can be found in the attached poster.
You can submit your abstract by following this link.
This event on Friday 15th November is an exceptional opportunity to address the underlying causes of cancer health inequalities by actively engaging with global stakeholders, including policymakers.
We have already secured the participation of distinguished speakers for this event. Information regarding registration will be made available in due course.
As someone deeply committed to the cause of combating cancer health inequalities, it is both a privilege and a pleasure for me to chair the steering committee for this event. I am eagerly anticipating the opportunity to gather with you all in November.
For more information, please visit.”
Olubukola Ayodele added a comment:
“We have received a significant number of high-quality abstracts, prompting us to extend the deadline by a week.
The new deadline for submitting abstracts for the esteemed Vanessa Moss prize is now September 1, 2024.
Please find the submission link.
All the best!”
Source: Olubukola Ayodele/LinkedIn
For more posts by Olubukola Ayodele, visit oncodaily.com
Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre.
Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.